{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-76",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-76.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "regulation/76",
  "kind": "regulation",
  "number": "76",
  "heading": "Limitation on withdrawal from pharmaceutical lists while fitness investigations or proceedings are ongoing",
  "text": "(1) If NHS England would otherwise remove an NHS chemist (C) from a pharmaceutical list under regulation 75, but—\n(a) is investigating C in order to see whether there are grounds for exercising its powers in relation to C under section 151, 152 or 154 of the 2006 Act (which relate to disqualification of practitioners, contingent removal and suspension), or regulation 80;\n(b) has decided to—\n(i) remove C from a pharmaceutical list under section 151 or 152 of the 2006 Act or regulation 80, or\n(ii) contingently remove C under section 152 of the 2006 Act,\nbut C has not yet been removed or contingently removed; or\n(c) has suspended C under section 154 of the 2006 Act,\nit must not, without the consent of the Secretary of State, remove C from that pharmaceutical list under regulation 75 until the relevant investigation or proceedings have been concluded.\n(2) If C's name is kept on a pharmaceutical list pursuant to paragraph (1)—\n(a) as regards C, NHS England may exercise its functions under—\n(i) Part 11 of these Regulations, and\n(ii) Chapter 6 of Part 7 of the 2006 Act (pharmaceutical services and local pharmaceutical services – disqualification); but\n(b) for all other purposes, C is to be treated as having been removed from that pharmaceutical list under regulation 75.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "Section 154 has been amended by S.I. 2010/22."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/regulation/76",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}